These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20647274)

  • 21. Psoriatic onychopachydermoperiostitis: improvement with etanercept.
    Dans M; Hivnor C; van Voorhees AS
    Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482
    [No Abstract]   [Full Text] [Related]  

  • 22. [Innovative therapeutic options for psoriatic arthritis: TNFalpha inhibitors].
    Lehnen M; Goos M; Dissemond J
    Dtsch Med Wochenschr; 2004 Mar; 129(12):634-8. PubMed ID: 15011134
    [No Abstract]   [Full Text] [Related]  

  • 23. Carotid intima-media thickness in subclinical hypothyroidism.
    Ghasemi M; Mousavi SA; Rezvanian H; Asadi B; Khorvash F; Fatehi F
    Int J Stroke; 2010 Apr; 5(2):131-2. PubMed ID: 20446948
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
    Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 27. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
    Turkiewicz AM; Moreland LW
    Arthritis Rheum; 2007 Apr; 56(4):1051-66. PubMed ID: 17393414
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden.
    Gülfe A; Kristensen LE; Saxne T; Jacobsson LT; Petersson IF; Geborek P
    Ann Rheum Dis; 2010 Feb; 69(2):352-7. PubMed ID: 19282310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].
    Manger B;
    Z Rheumatol; 2002 Dec; 61(6):694-7. PubMed ID: 12491133
    [No Abstract]   [Full Text] [Related]  

  • 30. Asymmetric dimethylorginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome.
    Verit FF; Vural M
    Fertil Steril; 2009 Jul; 92(1):e12; author reply e13. PubMed ID: 19482274
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract]   [Full Text] [Related]  

  • 32. Carotid intima-media thickness in type 1 diabetes mellitus.
    Köz C
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):59-60. PubMed ID: 20150007
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis.
    Pompella A; Emdin M; Paolicchi A; Franzini M
    Angiology; 2011 Feb; 62(2):105-6. PubMed ID: 21220369
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations on the management of psoriatic arthritis].
    Passeron T; Goupille P; Boulinguez S
    Ann Dermatol Venereol; 2011 Jun; 138(6 Suppl 1):H10-2. PubMed ID: 21703468
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis.
    Stompór T; Kraśniak A; Sułowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tabor B; Kowalczyk-Michałek ME; Zdzienicka A; Janusz-Grzybowska E
    Nephrol Dial Transplant; 2005 Feb; 20(2):404-12. PubMed ID: 15618238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Pasquetti P; Olivieri I; Salvarani C
    J Rheumatol Suppl; 2009 Aug; 83():78-80. PubMed ID: 19661551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
    Antoni C; Manger B
    Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].
    Ferraro S; Paolillo S; Gargiulo M; Costanzo P; Maggi P; Chirianni A; Chiariello M; Filardi PP
    G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor inhibitors continuation rates in patients with psoriatic arthritis: A French retrospective monocentre study.
    Rio S; Vincent FB; Michel M; Cesini J; Marcelli C
    Joint Bone Spine; 2015 Oct; 82(5):377-8. PubMed ID: 25677408
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spondyloarthritis including psoriatic arthritis].
    Rudwaleit M; Märker-Hermann E
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2033-6. PubMed ID: 21960334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.